Brief: Botanix Pharmaceuticals Seeks Trading Halt Pending Announcement In Relation To Clinical Study Results
11/10/2022 23:52
Oct 12 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT IN RELATION TO
CLINICAL STUDY RESULTS
Source text for Eikon: ID:nASXgx2w7
Further company coverage: BOT.AX
(Reporting by Poonam Behura)
((Poonam.Behura@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million